(REPRINTED WITH ADOPTED AMENDMENTS)

 

Assembly Bill No. 226–Assemblymen Angle, Berman,
Cegavske, Hettrick, Lee and Price

 

February 22, 2001

____________

 

Joint Sponsor: Senator Washington

____________

 

Referred to Committee on Education

 

SUMMARY—Makes various changes relating to treatment of pupils. (BDR 34‑88)

 

FISCAL NOTE:            Effect on Local Government: No.

                                    Effect on the State: No.

 

~

 

EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.

 

AN ACT relating to education; prohibiting an employee or agent of a school district from taking certain actions with regard to pupils; authorizing certain employees of a school district to suggest that a pupil be evaluated for placement in a special program; and providing other matters properly relating thereto.

 

THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN

SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:

 

1-1    Section 1. Chapter 392 of NRS is hereby amended by adding thereto a

1-2  new section to read as follows:

1-3    1.  A person who is an employee or agent of a school district shall

1-4  not:

1-5    (a) Suggest to a pupil or to a parent or guardian of the pupil that the

1-6  pupil should take a psychotropic drug unless the person is a physician;

1-7  and

1-8    (b) Prohibit a pupil from attending class unless the pupil takes a

1-9  psychotropic drug.

1-10    2.  A person who is an employee or agent of a school district may

1-11  suggest that the pupil be evaluated for determination of whether the pupil

1-12  should be placed in a special program pursuant to NRS 388.470.

1-13    3.  As used in this section:

1-14    (a) “Physician” means a person who is licensed to practice medicine

1-15  as a physician pursuant to chapter 630 of NRS.

1-16    (b) “Psychotropic drug” means a controlled substance listed in

1-17  schedule II by the state board of pharmacy pursuant to NRS 453.146, or

2-1  a neuroleptic or other psychoactive drug which produces a mind-altering

2-2  effect in a person.

2-3    Sec. 2.  This act becomes effective on July 1, 2001.

 

2-4  H